Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Nephrology

Understanding Your ADPKD Diagnosis

At a Glance

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a slow-progressing genetic condition that causes cysts to grow in the kidneys. While currently incurable, early intervention through blood pressure control, medications, and lifestyle changes can significantly slow disease progression.

Receiving a diagnosis of Autosomal Dominant Polycystic Kidney Disease (ADPKD) can feel like a heavy weight, often bringing a mix of shock, fear, and uncertainty about the future [1][2]. It is completely normal to feel overwhelmed by the knowledge that this is a genetic condition that may affect your family [3]. Understanding the facts about ADPKD is the first step toward regaining a sense of control and making informed decisions about your health.

What is ADPKD?

ADPKD is a genetic condition characterized by the growth of numerous cysts—small, fluid-filled sacs—within the kidneys [4]. Over many years, these cysts gradually increase in size and number, which can eventually crowd out healthy kidney tissue and impair the kidneys’ ability to filter waste from your blood [4][5].

While the term “kidney disease” sounds urgent, ADPKD is typically a slow-moving condition [5][6]. It is the most common inherited kidney disorder, affecting approximately 1 in every 400 to 1,000 people worldwide [7].

Navigating the Emotional Impact

The realization that ADPKD is inherited often adds a layer of psychological distress beyond the physical diagnosis [1]. Patients frequently report “genetic guilt” or anxiety regarding the possibility of passing the condition to their children [3][8]. These feelings are valid and are a recognized part of the ADPKD journey [1].

Many people find that their quality of life is affected more by the stress of the diagnosis than by the physical symptoms in the early stages [1][9]. Seeking clear, professional guidance and connecting with others who share the diagnosis can significantly help alleviate these concerns [2].

Three Stabilizing Facts for the Newly Diagnosed

While every person’s journey with ADPKD is unique, these three facts can help provide a more balanced perspective on what to expect:

  1. Progression is usually gradual: For most people, ADPKD is not an overnight crisis. Kidney function typically declines very slowly over several decades [5]. Many individuals maintain good kidney function well into their 50s or 60s, and some may never reach kidney failure [6][10]. Even in the worst-case scenario where kidney failure occurs, patients with ADPKD generally make excellent candidates for kidney transplants [10].
  2. Total Kidney Volume (TKV) is a powerful tool: Doctors now use a measurement called Total Kidney Volume (TKV)—the combined size of both kidneys—as a reliable way to track the disease [11]. By monitoring changes in TKV, your care team can better predict your personal risk of progression and tailor your treatment plan accordingly [11][12].
  3. Proactive management makes a difference: While there is currently no cure, there are more ways than ever to manage the condition. Controlling blood pressure is one of the most effective ways to protect your kidneys [13][14]. Additionally, new medications and emerging lifestyle adjustments (like plant-focused diets) are proving effective at slowing cyst growth [15][14][16].

Moving Forward with Confidence

Your diagnosis is the start of a new chapter, but it does not define your entire future. By working with a multidisciplinary team—which may include a nephrologist (kidney specialist), a genetic counselor, and a mental health professional—you can create a proactive plan to protect your health and manage the emotional complexities of an inherited condition [17][3]. Knowledge and early intervention are your most powerful tools for maintaining your long-term well-being [17][18].

Common questions in this guide

How quickly does ADPKD progress?
ADPKD is usually a slow-moving condition. For most patients, kidney function declines very gradually over several decades, and many individuals maintain good kidney function well into their 50s or 60s.
What is Total Kidney Volume (TKV) and why is it important?
Total Kidney Volume (TKV) is a measurement of the combined size of both of your kidneys. Doctors use TKV as a reliable tool to track cyst growth, monitor the disease, and predict your personal risk of progression over time.
Is there a cure for ADPKD?
While there is currently no cure for ADPKD, it is highly manageable. Proactive steps like aggressively controlling your blood pressure, taking specialized medications, and adopting a plant-focused diet can effectively slow down cyst growth.
Should I see a genetic counselor for my ADPKD diagnosis?
Yes, working with a genetic counselor is highly recommended. Because ADPKD is inherited, a genetic counselor can help you navigate family planning, testing options for relatives, and the emotional weight of a genetic diagnosis.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my specific genetic variant (PKD1 or PKD2), what is the typical timeline for kidney function changes?
  2. 2.What is my current Total Kidney Volume (TKV), and how does this measurement help us predict my disease progression?
  3. 3.How can we screen for or manage 'extrarenal' complications, such as high blood pressure or aneurysms, early on?
  4. 4.What lifestyle changes, such as diet or fluid intake, have been proven to slow the growth of cysts for someone in my specific situation?
  5. 5.Can you recommend a genetic counselor or a support group to help my family and me navigate the emotional aspects of this diagnosis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    [Quality of life in patients with autosomal dominant polycystic kidney disease].

    Lecardeur L, Joly D

    Nephrologie & therapeutique 2017; (13(7)):505-510 doi:10.1016/j.nephro.2016.12.005.

    PMID: 28606406
  2. 2

    What are the information needs and concerns of individuals with Polycystic Kidney Disease? Results of an online survey using Facebook and social listening analysis.

    Ma T, Lambert K

    BMC nephrology 2021; (22(1)):263 doi:10.1186/s12882-021-02472-1.

    PMID: 34261447
  3. 3

    International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people.

    Gimpel C, Bergmann C, Bockenhauer D, et al.

    Nature reviews. Nephrology 2019; (15(11)):713-726 doi:10.1038/s41581-019-0155-2.

    PMID: 31118499
  4. 4

    Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) During Pregnancy: Risks and Challenges.

    McBride L, Wilkinson C, Jesudason S

    International journal of women's health 2020; (12()):409-422 doi:10.2147/IJWH.S204997.

    PMID: 32547249
  5. 5

    Burden of Proof for Tolvaptan in ADPKD: Did REPRISE Provide the Answer?

    Mustafa RA, Yu ASL

    Clinical journal of the American Society of Nephrology : CJASN 2018; (13(7)):1107-1109 doi:10.2215/CJN.00190118.

    PMID: 29653956
  6. 6

    Atypical Polycystic Kidney Disease as defined by Imaging.

    Iliuta IA, Win AZ, Lanktree MB, et al.

    Scientific reports 2023; (13(1)):2952 doi:10.1038/s41598-022-24104-w.

    PMID: 36807559
  7. 7

    Copy Number Variation: A New Genetic Form of Polycystic Kidney and Liver Disease.

    Fujimaru T, Sohara E

    Kidney international reports 2020; (5(5)):575-576 doi:10.1016/j.ekir.2020.03.007.

    PMID: 32406422
  8. 8

    Mental Health and Autosomal Dominant Polycystic Kidney Disease: A Narrative Review.

    Ebrahimi N, Garimella PS, Chebib FT, et al.

    Kidney360 2024; (5(8)):1200-1206 doi:10.34067/KID.0000000000000504.

    PMID: 38976329
  9. 9

    Pain Management in Autosomal Dominant Polycystic Kidney Disease: Clinical Challenges and a Stepwise Algorithmic Approach.

    Borghol AH, Munairdjy Debeh FG, Ghanem A, et al.

    Kidney360 2025; (6(9)):1618-1631 doi:10.34067/KID.0000000907.

    PMID: 40622770
  10. 10

    Clinical Characteristics and Kidney Outcomes in Chinese Patients with Autosomal Dominant Polycystic Kidney Disease.

    Fung WW, Szeto CC, Chow KM, et al.

    Kidney360 2024; (5(5)):715-723 doi:10.34067/KID.0000000000000433.

    PMID: 38556647
  11. 11

    Hemorrhagic Cysts and Other MR Biomarkers for Predicting Renal Dysfunction Progression in Autosomal Dominant Polycystic Kidney Disease.

    Riyahi S, Dev H, Blumenfeld JD, et al.

    Journal of magnetic resonance imaging : JMRI 2021; (53(2)):564-576 doi:10.1002/jmri.27360.

    PMID: 32969110
  12. 12

    Anterior Cerebral Artery Dissection in a Patient With Autosomal Dominant Polycystic Kidney Disease.

    Tanaka M, Takasugi J, Hatate J, et al.

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2019; (28(9)):e129-e131 doi:10.1016/j.jstrokecerebrovasdis.2019.06.026.

    PMID: 31296478
  13. 13

    Prevalence of Hypertension in Children with Early-Stage ADPKD.

    Massella L, Mekahli D, Paripović D, et al.

    Clinical journal of the American Society of Nephrology : CJASN 2018; (13(6)):874-883 doi:10.2215/CJN.11401017.

    PMID: 29674338
  14. 14

    Nonpharmacological Management of Autosomal Dominant Polycystic Kidney Disease.

    Steele CN, Nowak KL

    Advances in kidney disease and health 2023; (30(3)):220-227 doi:10.1053/j.akdh.2022.12.008.

    PMID: 37088524
  15. 15

    A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney disease.

    Mader G, Mladsi D, Sanon M, et al.

    BMC nephrology 2022; (23(1)):334 doi:10.1186/s12882-022-02956-8.

    PMID: 36258169
  16. 16

    A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease.

    Kipp KR, Rezaei M, Lin L, et al.

    American journal of physiology. Renal physiology 2016; (310(8)):F726-F731 doi:10.1152/ajprenal.00551.2015.

    PMID: 26764208
  17. 17

    Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies.

    Lanktree MB, Haghighi A, di Bari I, et al.

    Clinical journal of the American Society of Nephrology : CJASN 2021; (16(5)):790-799 doi:10.2215/CJN.02320220.

    PMID: 32690722
  18. 18

    New treatment paradigms for ADPKD: moving towards precision medicine.

    Lanktree MB, Chapman AB

    Nature reviews. Nephrology 2017; (13(12)):750-768 doi:10.1038/nrneph.2017.127.

    PMID: 28989174

This page provides an overview of an ADPKD diagnosis for educational purposes only. Always consult your nephrologist or genetic counselor for guidance on your specific disease progression and treatment plan.

Get notified when new evidence is published on Autosomal dominant polycystic kidney disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.